News, views and contacts from the global Pharmaceutical industry

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

June 2016

Top

Report: Licensing deal values in the pharmaceutical industry surged in 2015, led by Sanofi 24 June 2016 The value of licensing deals in the pharmaceutical industry reached $46.2bn last year, recording a signigicant growth of 37.1% over last year’s $33.7bn, says a whitepaper by GlobalData....

Scientists reveal hops extract could help reduce breast cancer 24 June 2016 Scientists have revealed that new lab investigations on breast cells using extracts from hops, the flower cones used to make beer, could help fight breast cancer....

PaxVax receives ACIP recommendation for Vaxchora cholera vaccine 24 June 2016 The US Centres for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices (ACIP) has recommended use of US-based biotechnology company PaxVax's single-dose oral,...

New report says leukaemia has largest active development pipeline 23 June 2016 Leukaemia has the largest pipeline in active development from the three major indications within haematological cancer, also comprising lymphoma and myeloma, according to a new report by...

Orion and Asahi Kasei reach agreement for pain management assets 23 June 2016 Finnish pharmaceutical and diagnostics company Orion has entered a global strategic collaboration agreement with Japan-based Asahi Kasei Pharma to discover, develop and commercialise assets in...

US NHRC commences clinical trial of norovirus vaccine at RTC 22 June 2016 The US Naval Health Research Centre (NHRC) has launched a clinical trial at Recruit Training Command (RTC) in a bid to assess the effectiveness of the first norovirus vaccine in reducing...

AbbVie, Eisai and EA Pharma receive additional approval for new Humira dosing regimen 22 June 2016 AbbVie GK, the Japanese subsidiary of AbbVie, Eisai and its subsidiary EA Pharma have received the additional approval for a new dosing regimen of Humira Pre-filled Syringe 40mg / 0.8mL...

UK NICE grants Technology Appraisal Guidance for Sanofi’s Praluent (alirocumab) 22 June 2016 The UK National Institute for Health and Care Excellence (NICE) has granted Technology Appraisal Guidance (TAG) for French pharmaceutical company Sanofi’s latest cholesterol-lowering...

Indian firm Zydus Cadila purchases two ANDAs from Teva 21 June 2016 Indian pharmaceutical company Zydus Cadila has acquired two abbreviated new drug applications (ANDAs) from Israeli-American pharmaceutical company...

New study finds 20-dose course of prostate cancer radiotherapy reduces hospital visits in UK 21 June 2016 Researchers at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust have revealed that a shorter course of prostate cancer radiotherapy is as effective as...

F2G raises $60m in financing to develop invasive fungal infections therapies 21 June 2016 UK-based antifungal drug discovery and development company F2G has raised $60m in financing to develop its pipeline of novel therapies for treating life threatening invasive fungal...

NICE issues Final Appraisal Determination for Vertex’s Orkambi to treat cystic fibrosis 20 June 2016 The National Institute for Health and Care Excellence (NICE) in the UK has issued a Final Appraisal Determination (FAD) for Massachusetts-based pharmaceutical company Vertex’s Orkambi (lumacaftor...

New analysis reveals Brexit would affect UK pharmaceutical industry 20 June 2016 An analysis by pharmaceutical and life sciences recruitment consultancy NonStop Recruitment has revealed that Britain's exit (Brexit) from the European Union (EU) entails the possibility...

Shield Therapeutics launches Feraccru to treat IDA in IBD patients in UK 20 June 2016 Specialist pharmaceutical company Shield Therapeutics has launched Feraccru (ferric maltol) within the UK to treat adults with iron deficiency anaemia (IDA) in patients affected with...

US biotechnology firm Illumina signs deals to provide GSA samples to 12 customers 17 June 2016 American biotechnology company Illumina has signed deals with 12 customers to provide them with more than three million samples for its new Infinium Global Screening Array...

Report: Rapid growth in global type 2 diabetes market to be fuelled by rising incidence of the disease 17 June 2016 The global type 2 diabetes market is projected to grow twofold by 2025 and reach $58.7bn, according to a report by GlobalData. The market will expand at a compound annual growth rate of 6.5%...

M&As this week: Trelleborg, Polpharma 17 June 2016 Trelleborg A.B. plans to strengthen its position in the life sciences market and develop a strong platform in the sector by acquiring Speciality Silicone Fabricators, a manufacturer...

Deals this week: Organovo, Thermo Fisher Scientific, ImmunoGen 17 June 2016 Organovo Holdings and University of California, San Francisco, (UCSF) have entered a partnership to develop 3D Bioprinted Tissues for skeletal disease...

India’s Zydus Cadila and Eczacibasi to market biotech products in Turkey 17 June 2016 Indian pharmaceutical company Zydus Cadila has signed a strategic collaboration agreement with Turkish-based healthcare company Eczacıbaşı İlaç Pazarlama, in a bid to commercialise biotech...

New data finds middle-aged people more likely to be diagnosed with advanced lung cancer 16 June 2016 A new data presented at the Cancer Outcomes and Data Conference in Manchester, England, has revealed that middle-aged people between 50 and 64 years have a higher risk of being diagnosed with...

NIH-funded study finds proper maternal folate levels reduce childhood obesity 16 June 2016 A study led by the National Institutes of Health (NIH)-funded researchers has revealed that proper maternal folate levels during pregnancy may protect children from a future risk of...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511